Source:http://linkedlifedata.com/resource/pubmed/id/11985060
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0004083,
umls-concept:C0007222,
umls-concept:C0007820,
umls-concept:C0017431,
umls-concept:C0027481,
umls-concept:C0030705,
umls-concept:C0032105,
umls-concept:C0205307,
umls-concept:C0439603,
umls-concept:C0441889,
umls-concept:C0681850,
umls-concept:C1550501,
umls-concept:C1706203,
umls-concept:C1882417,
umls-concept:C2349001,
umls-concept:C2603343,
umls-concept:C2697811
|
pubmed:issue |
3
|
pubmed:dateCreated |
2002-5-2
|
pubmed:abstractText |
Atrial natriuretic peptide (ANP) plays a crucial role in regulating body fluid volume and blood pressure, by promoting natriuresis and vasodilatation and by inhibiting the renin-angiotensin system. Plasma levels of ANP are elevated in heart failure and hypertension, and ANP is thus believed to be involved in the pathogenesis of cardiovascular disorders. Previous case-control studies have shown that a single nucleotide polymorphism in the first exon of ANP gene, 664G/A, is associated with a risk of cerebrovascular disease (CVD) in white populations. Plasma ANP levels, however, were not evaluated in these studies in relation to the 664G/A, although the nucleotide substitution causes an amino-acid change in the propeptide of ANP. In this study, we analyzed the genotype frequencies of the 664G/A in Japanese patients with CVD (n = 199) and age- and gender-matched control subjects(n = 176). Genotypes with the 664A allele in the Japanese control subjects (G/A and A/A 12.5%) were apparently more frequent compared to the published frequency of the white control population (G/A and A/A 6.6%, p = 0.0437). Genotypes with the 664A allele, however, were not significantly different between our CVD patients(15.1%) and controls (12.5% p = 0.4714). In the control group (n = 137), the mean plasma ANP levels were not different between the 664G/G (15.7 +/- 10.7 pg/ml) and 664G/A genotypes (15.6 +/- 6.8 pg/ml, p = 0.9708). These results suggest that there is a racial difference in the allele frequency of 664G/A, and that this polymorphism may not be a major risk factor for CVD in the Japanese, nor is it a major determinant of plasma ANP level.
|
pubmed:language |
jpn
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0047-1860
|
pubmed:author |
pubmed-author:FukuuchiYasuoY,
pubmed-author:ItoDaisukeD,
pubmed-author:KikuchiHaruhitoH,
pubmed-author:MurataMitsuruM,
pubmed-author:OhtaAtsumiA,
pubmed-author:SaitoIkuoI,
pubmed-author:SonodaAkiraA,
pubmed-author:TakeshitaEikoE,
pubmed-author:TanahashiNorioN,
pubmed-author:WatanabeKiyoakiK,
pubmed-author:YatabeYokoY
|
pubmed:issnType |
Print
|
pubmed:volume |
50
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
296-300
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:11985060-Atrial Natriuretic Factor,
pubmed-meshheading:11985060-Cerebrovascular Disorders,
pubmed-meshheading:11985060-Female,
pubmed-meshheading:11985060-Gene Frequency,
pubmed-meshheading:11985060-Genotype,
pubmed-meshheading:11985060-Humans,
pubmed-meshheading:11985060-Male,
pubmed-meshheading:11985060-Middle Aged,
pubmed-meshheading:11985060-Polymorphism, Genetic,
pubmed-meshheading:11985060-Polymorphism, Restriction Fragment Length
|
pubmed:year |
2002
|
pubmed:articleTitle |
[Study of genotype frequencies of ANP 664G/A polymorphism in normal subjects and CVD patients, and its association with plasma ANP levels].
|
pubmed:affiliation |
Department of Laboratory Medicine, School of Medicine, Keio University, Shinjuku-ku, Tokyo 161-8582.
|
pubmed:publicationType |
Journal Article,
English Abstract
|